Market Research

Clot Management Devices Market By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF)) , By End User (Diagnostic Cent

Best Price Guarantee Length Publisher Published Date SKU
from $4,425 280 Pages Allied Market Research September, 2024 ALMR19510340
Best Price Guarantee
Price from $4,425
Length 280 Pages
Publisher Allied Market Research
Published Date September, 2024
SKU ALMR19510340

Clot Management Devices Market By Product (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF)) , By End User (Diagnostic Centers, Hospitals) : Global Opportunity Analysis and Industry Forecast, 2024-2033


Clot Management Devices Market

The clot management devices market was valued at $1.9 billion in 2023 and is projected to reach $3.2 billion by 2033, growing at a CAGR of 5.2% from 2024 to 2033.

A clot management device is an equipment that restores proper circulation of blood in a living body by removing or dissolving coagulated blood. It is primarily used in conditions such as deep vein thrombosis, pulmonary embolism, and arterial thrombosis. The device can be mechanical, chemical-based, laser-powered, or compressional. Along with clot treatment, a clot management device monitors blood flow in real time to improve patient outcomes.

Exponential growth in the aging population and increase in prevalence of thromboembolic disorders have boosted the demand for clot management devices, augmenting the development of the market. In addition, rise in awareness regarding the importance of circulatory and thromboembolic health has fueled periodic screening & diagnosis examinations among individuals, driving the growth of the market. Currently, the trend of integrating minimally invasive techniques and robotics is acquiring traction in the clot management devices market. The assimilation of these cutting-edge techniques improves the precision of operation, reduces the risk of complications, and lowers the recovery period.

However, the advent of technologically advanced clot management devices restrains the growth of the market as the high costs limit their adoption in small-scale healthcare facilities. Furthermore, inadequate reimbursement policies deter several medical institutions from investing in such expensive equipment, thereby hampering the market development. Moreover, concerns pertaining to blood vessel damage and infections after surgery hinder the market growth significantly. On the contrary, assimilation of telemedicine approach into the device to facilitate round-the-clock monitoring of patients in complicated cases is anticipated to present lucrative opportunities for the clot management devices market. According to the U.S. Center for Disease Control and Prevention, more than one-third of the diagnosed thromboembolic disorders occur due to recent hospitalization, which generally intensify after discharge. Therefore, telemedicine techniques are expected to facilitate continuous patient monitoring post-discharge, opening new avenues for the clot management devices market.

Segment Review

The clot management devices market is segmented into product, end user, and region. On the basis of product, the market is divided into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). Depending on end user, it is bifurcated into diagnostic centers and hospitals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the percutaneous thrombectomy devices segment held a high share of the market in 2023.

Depending on end user, the hospitals segment dominated the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players in the global clot management devices market include Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Incorporated, Edwards Lifesciences Corporation, Lemaitre Vascular, Inc., Vascular Solutions, Inc., Straub Medical AG, Cook Group, and Johnson & Johnson. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Key Market Segments

By Product

Neurovascular Embolectomy Devices
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Catheter-Directed Thrombolysis (CDT) Devices
Inferior Vena Cava Filters (IVCF)

By End User

Diagnostic Centers
Hospitals

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Medtronic
Boston Scientific Corporation
iVascular SLU
Teleflex Incorporated
Edwards Lifesciences Corporation
Lemaitre Vascular, Inc.
Vascular Solutions, Inc.
Straub Medical AG
Cook Group
Johnson & Johnson


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Neurovascular Embolectomy Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Embolectomy Balloon Catheters
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Percutaneous Thrombectomy Devices
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Catheter-Directed Thrombolysis (CDT) Devices
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Inferior Vena Cava Filters (IVCF)
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: CLOT MANAGEMENT DEVICES MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Diagnostic Centers
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Hospitals
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: CLOT MANAGEMENT DEVICES MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Clot Management Devices Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Clot Management Devices Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Clot Management Devices Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Clot Management Devices Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Clot Management Devices Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Clot Management Devices Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Clot Management Devices Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Clot Management Devices Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Clot Management Devices Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Clot Management Devices Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Clot Management Devices Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Clot Management Devices Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Clot Management Devices Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Clot Management Devices Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Clot Management Devices Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Clot Management Devices Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Clot Management Devices Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Clot Management Devices Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Clot Management Devices Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Boston Scientific Corporation
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. IVascular SLU
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Teleflex Incorporated
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Edwards Lifesciences Corporation
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Lemaitre Vascular, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Vascular Solutions, Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Straub Medical AG
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Cook Group
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Johnson And Johnson
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. CLOT MANAGEMENT DEVICES MARKET FOR NEUROVASCULAR EMBOLECTOMY DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. CLOT MANAGEMENT DEVICES MARKET FOR EMBOLECTOMY BALLOON CATHETERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. CLOT MANAGEMENT DEVICES MARKET FOR PERCUTANEOUS THROMBECTOMY DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. CLOT MANAGEMENT DEVICES MARKET FOR CATHETER-DIRECTED THROMBOLYSIS (CDT) DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. CLOT MANAGEMENT DEVICES MARKET FOR INFERIOR VENA CAVA FILTERS (IVCF), BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 8. CLOT MANAGEMENT DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. CLOT MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. CLOT MANAGEMENT DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA CLOT MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 14. U.S. CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 15. U.S. CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. CANADA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 17. CANADA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. MEXICO CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 19. MEXICO CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE CLOT MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 22. EUROPE CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 24. GERMANY CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. FRANCE CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 26. FRANCE CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. UK CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 28. UK CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. ITALY CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 30. ITALY CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. SPAIN CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 32. SPAIN CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. REST OF EUROPE CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. REST OF EUROPE CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 37. ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 39. JAPAN CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. CHINA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 41. CHINA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. AUSTRALIA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 43. AUSTRALIA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. INDIA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 45. INDIA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. SOUTH KOREA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 47. SOUTH KOREA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. REST OF ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 49. REST OF ASIA-PACIFIC CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA CLOT MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 52. LAMEA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. BRAZIL CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 54. BRAZIL CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 56. SAUDI ARABIA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. SOUTH AFRICA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 58. SOUTH AFRICA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. REST OF LAMEA CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 60. REST OF LAMEA CLOT MANAGEMENT DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. MEDTRONIC: KEY EXECUTIVES
TABLE 62. MEDTRONIC: COMPANY SNAPSHOT
TABLE 63. MEDTRONIC: OPERATING SEGMENTS
TABLE 64. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 65. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 66. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 67. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 68. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 69. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 70. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71. IVASCULAR SLU: KEY EXECUTIVES
TABLE 72. IVASCULAR SLU: COMPANY SNAPSHOT
TABLE 73. IVASCULAR SLU: OPERATING SEGMENTS
TABLE 74. IVASCULAR SLU: PRODUCT PORTFOLIO
TABLE 75. IVASCULAR SLU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 76. TELEFLEX INCORPORATED: KEY EXECUTIVES
TABLE 77. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 78. TELEFLEX INCORPORATED: OPERATING SEGMENTS
TABLE 79. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 80. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 82. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 83. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 84. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 85. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 86. LEMAITRE VASCULAR, INC.: KEY EXECUTIVES
TABLE 87. LEMAITRE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 88. LEMAITRE VASCULAR, INC.: OPERATING SEGMENTS
TABLE 89. LEMAITRE VASCULAR, INC.: PRODUCT PORTFOLIO
TABLE 90. LEMAITRE VASCULAR, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. VASCULAR SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 92. VASCULAR SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 93. VASCULAR SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 94. VASCULAR SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 95. VASCULAR SOLUTIONS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. STRAUB MEDICAL AG: KEY EXECUTIVES
TABLE 97. STRAUB MEDICAL AG: COMPANY SNAPSHOT
TABLE 98. STRAUB MEDICAL AG: OPERATING SEGMENTS
TABLE 99. STRAUB MEDICAL AG: PRODUCT PORTFOLIO
TABLE 100. STRAUB MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. COOK GROUP: KEY EXECUTIVES
TABLE 102. COOK GROUP: COMPANY SNAPSHOT
TABLE 103. COOK GROUP: OPERATING SEGMENTS
TABLE 104. COOK GROUP: PRODUCT PORTFOLIO
TABLE 105. COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 107. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 108. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 109. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 110. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL CLOT MANAGEMENT DEVICES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF CLOT MANAGEMENT DEVICES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN CLOT MANAGEMENT DEVICES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLOT MANAGEMENT DEVICES MARKET
FIGURE 10. GLOBAL CLOT MANAGEMENT DEVICES MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. CLOT MANAGEMENT DEVICES MARKET FOR NEUROVASCULAR EMBOLECTOMY DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. CLOT MANAGEMENT DEVICES MARKET FOR EMBOLECTOMY BALLOON CATHETERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. CLOT MANAGEMENT DEVICES MARKET FOR PERCUTANEOUS THROMBECTOMY DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. CLOT MANAGEMENT DEVICES MARKET FOR CATHETER-DIRECTED THROMBOLYSIS (CDT) DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. CLOT MANAGEMENT DEVICES MARKET FOR INFERIOR VENA CAVA FILTERS (IVCF), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL CLOT MANAGEMENT DEVICES MARKET SEGMENTATION, BY END USER
FIGURE 17. CLOT MANAGEMENT DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. CLOT MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 23. COMPETITIVE DASHBOARD
FIGURE 24. COMPETITIVE HEATMAP: CLOT MANAGEMENT DEVICES MARKET
FIGURE 25. TOP PLAYER POSITIONING, 2023
FIGURE 26. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 27. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 29. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. IVASCULAR SLU: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. IVASCULAR SLU: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. IVASCULAR SLU: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. TELEFLEX INCORPORATED: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. LEMAITRE VASCULAR, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. LEMAITRE VASCULAR, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. LEMAITRE VASCULAR, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. VASCULAR SOLUTIONS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. VASCULAR SOLUTIONS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. VASCULAR SOLUTIONS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. STRAUB MEDICAL AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. STRAUB MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. STRAUB MEDICAL AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. COOK GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. COOK GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. COOK GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)

$4,425
$7,412

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings